Discover 2,356 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,356
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Location: Anaheim CA, Los Alamitos CA, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07787169
Phase 1, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Anaheim CA, Los Alamitos CA, Loma Linda CA, Redlands CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
New
A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or Obesity
for
Overweight and/or Obesity, Healthy Participants
Location: Anaheim CA
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07876531
Phase 1, Recruiting
New
A Study to Assess the Relative Bioavailability of Irafamdastat (BMS-986368) and to Assess the Food Effect on the Pharmacokinetics of Irafamdastat in Healthy Adult Participants
for
Healthy Volunteers
Location: Anaheim CA
Sponsor: Celgene
Sex: All
Age: 18 - 55
Code: NCT07837115
Phase 1, Recruiting
New
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Anaheim CA, Los Alamitos CA, Walnut Creek CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07881887
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
Location: Anaheim CA, Los Alamitos CA, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07843459
Phase 1, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration